Skip to main content

Squamous Cell Carcinoma News (Page 2)

Related terms: Cancer, Squamous Cell Carcinoma, Skin Cancer, Squamous Cell, SCC

FDA Approves Merck’s Keytruda (pembrolizumab) for the Treatment of Patients with Recurrent or Metastatic Cutaneous Squamous Cell Carcinoma (cSCC) that is Not Curable by Surgery or Radiation

KENILWORTH, N.J.--(BUSINESS WIRE)-- Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today that the U.S. Food and Drug Administration (FDA) has approved Keytruda,...

FDA Approves Libtayo (cemiplimab-rwlc) for Advanced Cutaneous Squamous Cell Carcinoma

September 28, 2018 – The U.S. Food and Drug Administration today approved Libtayo (cemiplimab-rwlc) injection for intravenous use for the treatment of patients with metastatic cutaneous squamous...

Ask a question

To post your own question to our community, sign in or create an account.

Further information

Related condition support groups

Skin Cancer

Related drug support groups

Keytruda